New York And Munich

Positive Phase 2 Trial Results From Neuroendocrine Tumor Cohort Presented at CIRSE

Older News

NEW YORK and MUNICH, September 13, 2011 - Chemosaturation Demonstrates Clinically Meaningful Tumor Response with Unresectable Neuroendocrine Tumors in the Liver Delcath Systems, Inc.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy